The Chemistry and Biology of Bioflavonoids

 

Amit Tapas1*, Dinesh Sakarkar1, Rajendra Kakde2

 

1Sudhakarrao Naik Institute of Pharmacy, Pusad- 445204, Dist.-Yavatmal (MS) India

2University Department of Pharmaceutical Sciences, R.T.M. Nagpur University, Nagpur-440033 (MS) India

* Corresponding Author E-mail: amit.tapas@gmail.com

 

ABSTRACT

Phenolic compounds form one of the main class of secondary metabolites. They display a large range of structures and

are responsible for the major organoleptic characteristics of plant-derived-foods and beverages, particularly color and taste properties and they also contribute to the nutritional qualities of fruits and vegetables. Among these compounds flavonoids constitute one of the most ubiquitous groups of all plant phenolics. Owing to their importance in food organoleptic properties and in human health, a better understanding of their structure, biosynthesis, chemical synthetic methodologies and various biological activities appears essential to make them as potential therapeutic agents and also to predict  and  control  food  quality.  The  purpose  of  this  work  is  an  overvieof  structural  diversities,  synthetic methodologies and shed a light on biological activities. The first part of this review concerns the structural aspects, biosynthetic and synthetic schemes for different classes of flavonoids. Regarding the synthesis of flavonoids various schemes have been highlighted to obtain variety of higher potent flavonoid derivatives. These schemes can be applicable at regular laboratory levels. The second part of this review concerns the various biological properties of flavonoids on plant as well as on mammalian cells. Recently this group of natural products has gained much interest as bioactive compounds. Because of the variety of pharmacological activities on mammalian body flavonoids are more correctly referred asNutraceutical”.

 

 KEY WORDS              Bioflavonoids; Chemistry; Biological Activities; Review.                              

 


INTRODUCTION:

Phenolic compounds form one of the  main class of

secondary metabolites. They display a large range of structures  and  are  responsible  for  the  major organoleptic characteristics of plant-derived-foods and beverages, particularly color and taste properties and they also contribute to the nutritional qualities of fruits and vegetables. Among these compounds flavonoids constitute one  of  the  most  ubiquitous groups of  all plant phenolics. The most important natural pigments are carotenoids, tetrapyrrole derivatives of naturally occurring phenolic compounds ubiquitously distributed in plant kingdom. So far over 8,000 varieties of flavonoids have been identified1. Until ~50 years ago, information on the working mechanisms of flavonoids was scare. But it has been widely known for centuries that   compound o plan origin   possesses   broad spectrum of biological activity2. In 1930, Szent- Gyorgyi isolated a new substance from oranges and classifies it as a vitamin, Vitamin P. But latter it came clear that this substance was a flavonoid. Flavonoids have created a more attention of researcher with the discovery of the French Paradox, i.e. decrease incidence of cadio-vascular disease observed in Mediterranean population, in association with  red  wine  consumption  and  a  greater  amount  of saturated fat than average diet in other countries3. In this review it  is  attempted to  describe current  knowledge on structural aspects, biosynthetic and synthetic routes of flavonoids.

 

STRUCTURE AND CLASSIFICATION OF FLAVONOIDS:

Flavonoids occur as aglycones, glycosides and methylated derivatives4. In plants, flavonoids aglycones (i.e. flavonoids without attached sugar) occur in a variety in a variety of structural forms. All contain fifteen carbon atoms in their

basic nucleus: two six membered rings linked with a three carbon unit which may or may not be a part of third ring5. For convenience the rings are labeled A, B, and C. The individual carbon atoms are based on a numbering system, which uses ordinary numeral for the A and C and primednumerical  for  B-rin(1).  Primed  modified  numbering system is not used for chalcones (2) and the isoflavones derivatives (6):  the  pterocarpans and  the  rotenoids6The different ways to close this ring associated with the different oxidation degrees of ring A provide the various classes of flavonoids. linkage is normally located at position 3 or 7 and carbohydrate unit can be L-rhamnose, D-glucose, glucorhamnose, galactose or arabinose9. an Acetate  Malonate”  pathways,  th firs flavonoid initially formed in the biosynthesis is the chalcone and all other forms are derived from this variety of routes10. Further


Figure 1. Chemical structure of some representative flavonoids

 

 

The six member ring condensed with the benzene ring is either a γ-pyrone (flavones (1) flavonols (3)) or its dihydroderivative (flavanones (4) and flavan-3-ols (5)). The position of benzenoid substituent divides the flavonoids into two classes as flavonoids (1) (2- position)  and  isoflavonoid(6)  (3-position). Biflavonoid   (9) (10 is   dimmer   havin similar

(biflavone,   biflavanone)   o dissimilar   (flavanone-


modification  of  flavonoid  may  occur  at  various  stages

resulting in additional (or reduced) hydroxylation, methylation of  hydroxygroups or  of  flavonoid  nucleus, isoprenylation of hydroxyl groups or of the flavonoid nucleus, methylenation of ortho-dihyroxyl groups, dimerisation (to produce biflavonoids), bisulphate formation, and most importantly, glycosylation of hydroxyl groups (to produce flavonoid o-glycosides) or of flavonoid nucleus (to produce flavonoid C-glycosides)11-12.

 

 

Flavonoid ar synthesize via   th phenylpropanoid

13


flavone,      flavone-isoflavone,      flavanone-chalcone)


pathway


Phenylalanine ammonia lyase (PAL) catalyzes

14, 15


flavonoid moieties in their structure. These monomer


the conversion of phenylalanine to cinnamate


. PAL also


units usually bound to one another through C-6 or C-


shows  activity  with  converting  tyrosine  to  p-coumarate,

16


87.      In      prenylated      flavonoids      (11),      (12)


albeit to a lower efficiency


. The cinnamate 4-hydroxylase


prenyl/isopentenyl or their furano/dimethyl chromano


(C4H) catalyzes the synthesis of p-hydroxycinnamate from

17


derivatives, as well as the geranyl and farnesyl side


cinnamate and 4-coumarate


:CoA ligase (4CL) converts p-


attachment is present. Generally, the most flavonoids are C-prenylated and more frequently on ring A’ at position 6/8 as well as on position 3/5 especially in flavanones and flavones8. Most flavonoids occurs naturally associated with sugar in conjugated form and within any one class may be characterized as monoglycosidic, diglycosidic, etc. the glycosidic


coumarate to its coenzyme-A ester, activating it for reaction

with malonyl CoA18.

 

The flavonoid biosynthetic pathway starts with the condensation  of  one  molecule  of  4-coumaroyl-CoA  and three molecules of malonyl-CoA, yielding naringenin chalcone19. This reaction is carried out by the enzyme


 

Figure 3. Examples showing structures of somprenylated flavonoids. General Structure


 

Group

3

5

6

7

8

3

4

5

C2=C3

Flavones

 

Apigenin

H

OH

H

OH

H

H

OH

H

+

Diosmin

H

OH

H

Oru

H

OH

OH

H

+

Luteolin

H

OH

H

OH

H

OH

OH

H

+

Flavonol

 

Quercetin

OH

OH

H

OH

H

OH

OH

H

+

Kaempferol

OH

OH

H

OH

H

H

OH

H

+

Galangin

OH

OH

H

OH

H

H

H

H

+

Fisetin

OH

H

H

OH

H

OH

OH

H

+

Myricetin

OH

OH

H

OH

H

OH

OH

OH

+

Vitexicarpin

OCH3

OH

OCH

OCH3

H

OH

OCH3

H

+

Flavanone

 

Naringenin

H

OH

H

OH

H

H

OH

H

-

Eriodictyol

H

OH

OH

OH

H

OH

OH

H

-

Pinocembrin

H

OH

H

OH

H

H

H

H

-

Liquiritigenin

H

H

H

OH

H

H

OH

H

-

Flavanonol

 

Taxifolin

H

OH

H

OH

H

OH

OH

H

-

Isoflavone

 

Genistein

-

OH

H

OH

H

H

OH

H

+

Tectorigenin

-

OH

OCH3

OH

H

H

OH

H

+

Daidzein

-

H

H

OH

H

H

OH

H

+

Formononetin

-

H

H

OH

H

H

OCH3

H

+

Flavan-3-ols

 

(+) Catechin

βOH

OH

H

OH

H

OH

OH

H

-

(-) Epicatechin

αOH

OH

H

OH

H

OH

OH

H

-

(-) Epigallocatechin

αOH

OH

H

OH

H

OH

OH

OH

-

Flavylium Salts

 

Cyanidin

OH

OH

H

OH

H

OH

OH

H

-

Pelargonidine

OH

OH

H

OH

H

H

OH

H

-

 


chalcone synthase (CHS)19. Chalcone is isomerised to a flavanone by the enzyme chalcone flavanone isomerase (CHI)20. From these central intermediates, the pathway diverges into several side branches, each resulting in a different class of flavonoids. Flavanone 3-hydroxylase (F3H) catalyzes the stereospecific 3β-hydroxylation of (2S)-flavanones to dihydroflavonols21-24. For the biosynthesis of  anthocyanins, dihydroflavonol reductase (DFR) catalyzes the reduction of dihydroflavonols to flavan-3,4-diols (leucoanthocyanins)25, which are converted to anthocyanidins by anthocyanidin synthase (ANS)26-28. The formation of glucosides is catalyzed by UDP glucose-flavonoid 3-o-glucosyl transferase (UFGT), which stabilize the anthocyanidins by 3-O- glucosylation (Harborne 1994, Bohm 1998)29. The overview of the flavonoid pathway is presented in Figure 5. There is evidence that the enzymes involved in flavonoid metabolism might be acting as membrane- associated multienzyme complexes, which has implications on the overall efficiency, specificity, and regulation of the pathway (Stafford 1991, Winkel-Shirley 1999, 2001)30.

 

 

 

Figure 4. Interrelationship between flavonoids for biosynthetic pathways.


 

 


CHEMICAL SYNTHETIC ROUTES FOR FLAVONOIDS

Flavonoids have been a topic of research for more than

one century. Some scientist have been trying to get their extracts from different plants and different parts of plants, and some started a course of synthetic experiments to afford the flavonoids. The isolation of bioflavonoids is carried out via an extraction process, but usually the plants contain a variety of derivatives in low concentration. Thus a large amount of dried raw material and laborious chromatographic purification schemes are needed to isolate quantities of individual compounds. So synthetic routes may be useful to get selective flavonoid compounds. In this review, we have tried to focus various synthetic schemes available for flavonoids synthesis. Various methods have been reported regarding the synthesis of flavonoids. The interest in these methods is that these syntheses allow the establishment with certainty the structure of naturally occurring flavonoids by preparing them unequivocally from known starting materials. It was also  enabled  the  workers  to  elucidate  biosynthetic

31-33


heterocycle ring directly while in other cases some interconversion is necessary. Four classical flavonoid synthetic routes are reported to  be used namely Claisen- Schmidt, Baker-Venkataraman, Allan-Robinson and Algar- Flynn-Oyamada methods.

 

The most important intermediates to obtain

Chalcones

2-hydrox chalcones   (15)    are    the    most    important

intermediates for the synthesis of flavonoids like flavones, flavonols, 3-hydroxyflavanones and aurones. The formation of chalcone was reported to involve thClaisen-Schmidt condensation of aromatic aldehyde (14) with acetophenone (13) in the presence of alkali as a catalyst. (Figure 6) flavonoids can be prepared to study their usefulness as flavoring/coloring additive or as potential drugs.

Two major pathways

The  synthesis of  flavones was first reported around

1900. The methods those have synthetic importance are divided into two chemical routes (Figure 6).

1. Substitution of phenol with an α,β-unsaturated acyl chloride.

2. Substitution     of     an     acetophenone     with     a benzaldehyde, a benzoyl anhydride, or        benzoyl

chloride.

 

Table 2: Reactive oxygen species that can be scavenged or whose formation can be inhibited by flavonoids69-70.

 

O3(Superoxide anion)

One-electron  reduction  product  of  O2.  Produced  by  phagocytes,  formed  in  autoxidation  reactions

(flavoproteins, redox cyclin._g), and generated by oxidases (heme proteins).

HO2

Potonated form of O2.

H2O2 (Hydrogen Peroxide)

Two-electron reduction product of O2  formed from Oby dismutation or directly from O2. Reactivity of

O  and H O  is amplified in the presence._of heme proteins.       ._         ._

2                2    2

 

OH (Hydroxy radical)

Three-electrons reduction product of Ogenerated by Fenton reaction, transition metal (iron, copper)- catalysed Haber-Weiss reaction; also formed by decomposition of peroxynitrite produced by the reaction of O2 with NO. (Nitric oxide radical).

RO. (Alkoxy radical)

Example: Lipid radical (LO.).                                           ._

ROO. (Peroxyl radical)

Example: Lipid peroxy radical (LOO.) produced from organic hydroperoxide (e.g. lipid hydroperoxide,

LOOH), ROOH by hydrogen abstraction.

1O2

Singlet oxygen

 

Table 3: Characteristics of flavonoids structure for most effective radical-scavenging activity 71-73.

 

•    The catechol (O-dihydroxy) group in the ring confers great scavenging ability.

•      A pyrogallol (trihydroxy) group in ring B of a catechol, as in myricetin, produces even higher activity. The C2-C3 double bond of the C ring appears to increase scavenger activity because it confers stability to the phenoxy radical produced.

•      The 4-oxo (keto double bond at position 4 of the C ring), especially in association with the C2-C3 double bond, increases scavenger activity by delocalizing electrons from B-ring.

•      The 3-OH group on the C ring generates an extremely active scavenger; in fact, the combination of C2-C3 double bond and 4-oxo group appears to be the best combination on the top of the catechol group.

•    The 5-OH and 7-OH groups may also add scavenging potential in certain cases.

 

 


In addition to their contribution to color, flavonoids also  known to  provide UV-protection to  plants60. UV-B  is  band  of  lowest  wavelengtand  highest energy. It can penetrate the ozone layer in the stratosphere and hence potentially cause damage to plant life. Resistance to UV-B may take many forms, but one type of resistance could lie in flavonoid pigments, which are known to always present in green leaves. These flavonoids generally absorb in the 280-

315 nm region and thus capable of acting as UV filters. One of the undisputed functions of flavonoids and related polyphenols is their role in protecting plants against microbial invasion. This not only involves their presence in plants as constitutive agents but also their accumulation as phytoalexins in response to microbial attack61. The majority of flavonoids recognized as constitutive antifungal agents in plants are either isoflavonoids, flavans, or flavanones.

 

Role of Flavonoids in Animals

As these compounds have beneficial role in plants they

also known to posses variety of pharmacological activities on mammalian cells. Because of the variety of pharmacological activities on mammalian body flavonoids are more correctly referred as Nutraceutical”.


Flavonoids As Nutraceutical

Nutraceutical”  is  a  term  coined  in  1979  by  Stephen

DeFelice. It  is  defined  as  a  food  or  parts  of  food  that provide medical or health benefits, including the prevention and treatment of disease. Nutraceuticals may range from isolated nutrients, dietary supplements, and diets to genetically engineered designer food, herbal products, and processed products, such as cereals, soups, and beverages. The increasing interest in nutraceuticals reflects the fact that consumers hear about epidemiological studies indicating that a specific diet or component of the diet is associated with a lower   ris fo  certain   disease.   Th majo active nutraceutical ingredients in plants are flavonoids. As is typical for phenolic compounds, they can act as potent antioxidants and metal chelators. They also have log been recognized to possess anti-inflammatory, antiallergic, hepatoprotective, antithrombotic, antiviral, and anticarcinogenic activities, discussed below separately.

 

Antioxidant Activity

The  best-described  property  of  almost  every  group  of

flavonoids is their capacity to acts as antioxidants. The flavones and catechins seem to be the most powerful flavonoids for protecting the body against reactive oxygen species (ROS). Body cells and tissues are continuously threatened by the damage caused by free radicals and ROS,


 


which are produces during normal oxygen metabolism o ar induced   b exogeneous  damage62-63.   Free radicals and ROS have been implicated in a large number of human diseases64-65. Quercetin, Kaempferol, Morin, Myricetin and rutin by acting as antioxidant exhibited beneficial effects, such as anti-inflammatory, antiallergic, antiviral,  as  well  as  anticancer  activity. They have also been suggested to play a protective role in liver diseases, cataracts, and cardiovascular diseases. Quercetin and silybin acting as free radical scavengers were shown to exert a protective effect in liver reperfusion  ischemic  tissue  damage66-67.  The scavenging activity of flavonoids has been reported to be in the order: Myrcetin > Quercetin > Rhamnetin > Morin  >  Diosmetin  >  Naringenin  >  Apigenin  > Catechin > 5,7-dihydroxy-3,4,5-trimethoxyflavone > robinin > kaempferol > flavone68.

 

Antimicrobial Activity

Flavonoid an ester o phenolic   acid were

investigated for their antibacterial, antifungal and antiviral activities.

 

Antibacterial Activity

Antibacterial activity has been displayed by a number

of flavonoids. Quercetin has been reported to completely inhibit the growth by Staphylococcus aureus. Most of the flavonones having no sugar moiety showed antimicrobial activities whereas none of the flavonols and flavonolignans tested showed inhibitory activity on the microorganisms74.

 

Antifungal Activity

A number of flavonoids isolated from peel of tangerine

orange, when tested for fungistatic activity towards Deuterophoma tracheiphila were found to  be active; nobiletin and langeritin exhibited strong and weak activities respectively while hesperidin could stimulate fungal growth slightly. Chlorflavonin was the first chlorine-containing flavonoid-type antifungal antibiotic produced by strains of Aspergillus candidus75.

 

Antiviral Activity

Naturally occurring flavonoids with antiviral activity have  been  recognized  since  the  1940s,  but  only

recently have attempts been made to make synthetic modifications   o natural   compound to   improve antiviral activity. Quercetin, morin, rutin, dihydroquercetin (taxifolin), apigenin, catechin, and hesperidine have reported to possess antiviral activity against some of 11 types of viruses76. The antiviral activity appears to  be associated with nonglycosidic

compounds, and hydroxylation at the 3-position is apparently a prerequisite for antiviral activity. It has been found that flavonols are more active more active than flavones against Herpes simplex virus type 1 and order of importance was galangin>kaempferol> quercetin77. Recently, a natural plant flavonoid polymer


of  molecular  weigh2,10daltons  was  found  to  have antiviral activity against two strains of type 1 herpes type simplex virus and type 2 herpes simplex viruses78. Because of the world wide spread of HIV since 1980s, the investigatioof  the  antiviral  activity  of  flavonoids  has mainly  focused  on  HIV79.  There  have  appeared  several recent reports on anti-AIDS activity of flavonoids. Out of twenty eight flavonoids tested the flavans were generally more  effective thaflavones  and  flavonones in  selective inhibition of HIV-1 and HIV-2 or similar immunodeficiency virus infection80.

 

Effect on Gastrointestinal system

Antiulcer Activity

Som recen hav indicated   that   flavonoid possess

antiulcerogenic activity. Flavonoid glycosides oOcimum basilicum (Labiatae) decreases ulcer index, and inhibited the gastric acid and pepsin secretions in aspirin induced ulcers in rats81. Quercetin, Rutin, and Kaempferol administered intraperitoneally (25-100 mg/kg) inhibited dose-dependent gastric damage produced by acidified ethanol in rats82.

 

Hepatoprotective Activity

The liver is subject to acute and potentially lethal injury by

several substances, including phalloidin (the toxic constituents of thmushroom Amanita phalloides), CCl4, galactosamine, ethanol, another compounds. Flavonoids have also been found to possess hepatoprotective activity. In a study carried out to investigate the flavonoid derivatives silymarin, apigenin, quercetin, and naringenin, as putative therapeutic agents against microcrystin LR-induced hepatotoxicity, silymarin was found to be the most effective one83.  The  flavonoid  rutin  and  venorutoshowed regenerativand  hepatoprotective effects  in  experimental cirrhosis84.

Anti-inflammatory Activity

Anti-inflammatory activity of  flavonoids in  many animal

models have been reported. Flavone/ flavonol glycosides as well as flavonoid aglycons have been reported for significant anti-inflammatory activity in animal model of both, acute and chronic inflammation when given orally or topically85-86. Hesperidin, a citrus flavonoid possesses significant anti- inflammatory and analgesic effects87. Recently apigenin, luteolin and quercetin have been reported to exhibit anti- inflammatory activity88.

A number of reports have been published which demonstrate that flavonoids can modulate arachidonic acid metabolism via inhibition of cyclo-oxygenase (COX) and lipooxygenase activity (LO).  Also  it  has  been  speculated that  the  anti- inflammatory and anti-allergic properties of flavonoids are consequence of their inhibitory actions on arachidonic acid metabolism89. Among flavones/flavonols kaempferol, quercetin,  myricetinfisetin  reported  to  possess  LO  and COX inhibitory activity 90-91.

 

Antidiabetic effects

Flavonoids  especially  Quercetin  has  reported  to  possess

antidiabetic activity. Mahmood Vessal et al reported that


 


quercetin, a flavonoid with antioxidant activity brings abou th regeneration   o pancreatic   islets   and proprably increases insulin release in strptozotocin- induced diabetic rats; thus exerting its beneficial antidiabetic effects92. Also in another study, Hif and Howell reported that quercetin also stimulate insulin release and enhanced Ca2uptake from isolated islets cell which suggest a place for flavonoids in non- insulin-dependent diabetes93-94.

 

Effect on Cardiovascular system

Vasorelaxant agent

Th consumption  o flavonoids  may  prevent  the

endothelial dysfunction by enhancing the vasorelaxant process leading to  reduction of  arterial pressure95-96. Endothelial dysfunction represents critical event in the development of cardiovascular diseases and the major complication of atherosclerosis and arterial thrombus formation97.

The consumption of flavonoids can be able to prevent a number of cardiovascular diseases including hypertension and atherosclerosis98-99. Really many experimental studies have shown that these polyphenolic compounds may reduce the arterial pressure in rats and enhance the vasorelaxant process. The  endothelium  dependent  relaxation  induced  by


scavenge free radicals, thereby maintaining proper concentration of endothelial prostacyclin and nitric oxide107. One study showed that flavonoids are powerful antithrombotic agents in vitro and in vivo because of their inhibition of the activity of cyclooxegenase and lipoxigenase pathways108.

 

Cardioprotective effects

Recent interest in  flavonoids has  been  stimulated by the

potential health benefits arising from the antioxidant activity of these ployphenolic compounds.these are the result of their high propensity to transfer electrons, to chelate ferrous ions, and to scavenge reactive oxygen species109. Because of these properties, flavonoids have been considered as potential protectors against chronic cardiotoxicity caused by the cytostatic drug doxorubicin. Doxorubicin is very effective antitumor agents, but its clinical use is limited by the occurrence of a cumulative dose related cardiotoxicity, resulting in, for example, congestive heart failure (negative inotropic effect). In the recent report the cardiotoxicity of doxorubicin on the mouse left atrium has been inhibited by flavonoids, 7-monohydroxyethylrutoside and 7,3,4- trihydroxyethylrutoside (34)110-112. flavonoids has been well documented. Also investigators have demonstrated that Anthocyanin delphinidin exerts a significant endothelium dependent vasorelaxation100-101.

Antiatherosclerotic effects

Oxidative  modification  of  low-density  lipoproteins

(LDL) by free radicals is an early event in the pathogenesis of atherosclerosis. The rapid uptake of oxidatively modified LDL via a scavenger receptor leads to the formation of foam cells. Flavonoids may directly scavenge some radical species by acting as a chain braking antioxidant102. The ability of quercetin, and the quercetin glycosides, to protect LDL against oxidative modification has shown a significant protective effect103. Furthermore, a Japanese study reported  an  inverse  correlatiobetween  flavonoid intake and total plasma cholesterol concentrations104.

 

Antithrombogenic effects

Platelet   aggregatio play  pivotal   role   in   the

physiology of thrombotic disesases. Activated platelets adhering to vascular endothelium generate lipid peroxides and oxygen free radicals, which inhibit the endothelial formation of prostacyclin and nitrous oxide. It was shown in 1960s that tea pigment can reduce blood coagulability, increase fibrinolysis, and prevent platlet  adhesion  and  aggregation105.  Selected flavonoids, such quercetin, kaempferol, and myricetin were shown to be effective inhibitors of platelet aggregation in dogs and monkeys106. Flavonols are particularly antithrombotic because they directly


7-m on o hy d rox y eh ty lruto side (3 4)

 

Figure 14. Example for the chemical structure of a 7,3,4- trihydroxyethylrutoside (34).

 

Antineoplastic Activity

A sufficient number of flavonoids have exhibited antineoplastic activity. Several recent reviews have highlighted this activity of flavonoids. Detailed studies113-115 have revealed that quercetin exerted a dose dependent inhibition of  growth and colony formation. The flavonoids

kaempferol, catechin, toxifolin and fisetin also suppressed cell growth116-117. On screening antileukaemic efficacy of 28 naturally occurring and synthetic flavonoids on human promyelocytic leukaemic HL-60 cells, genistein, an isoflavone was found to have strong effect118-119.

 

Effect on Central Nervous System

Synthetic flavonoids like 6-bromoflavone and 6-bromo-3’-

nitroflavonewere  shown  to  displace  [3H]  flumazenil binding to  membranes frorat  cerebellum bunofrom spinal cord, indicating selectivity for the BZ-Omega receptor subtype, but latter was very potent than 6-bromoflavone. Results from two conflict tests in rats showed that these synthetic   flavonoids   posses anxiolytic   lik properties similar or superior to that of diazepam120.


 


 

Figure 15. The Links that indicating effects of flavonoids on different diseases.

 

TOXICITY OF FLAVONOIDS

Flavonoids are ubiquitous in plants foods and drinks

and therefore a significant quantity is consumed in our daily diet. The toxicity of flavonoids is very low in animals. For rats, the LD5is 2-10 gm per animal for most flavonoids. Similar doses humans are quite unrealistic. As a precaution, doses less than 1mg per adult per day have been recommended for humans121. Dunnick and Hailey reported that high doses of quercetin over several years might result in the formatioof  tumors  in  mice122.  However,  in  other long-term studies, no carcinogenicity was found123. Moreover, as describe earlier quercetin reported to be anti-mutagenic in vivo.

 

CONCLUSION AND PERSPECTIVE: Flavonoids comprise a vast array of biologically active compounds ubiquitous in plants, many of which have been used in traditional eastern medicine for thousands o years Als the constitute   an   unavoidable component of the diet. In the present review we have evoked detail structural aspects, pathways responsible for biosynthetic and chemical synthetic methodologies and biological properties of flavonoids. A biosynthetic pathway explores the flavonoid metabolism processes. Studies   o flavonoid   metabolism  ar increasingly intertwined with efforts to understand a wide array of other  primary  and  secondary  metabolic  systems.  It seems likely that flavonoid metabolism will continue to serve as an important and tractable experimental model for efforts to understand cellular metabolism for some time to come. Also this review focuses a light on the various chemical synthetic pathways of flavonoids. The synthesis of bioflavonoids represents a challenge for chemists i term o multi-step   synthesis   and regioselective  modification.  Among  all  the  methods reported in this review chalcones and diketones were frequently  registered  as  intermediates  of  flavonoid synthesis, which show that the aldolisation is the key step in flavonoid synthesis. So we have given direct focus  on  aldolisation  with  minimum  protection  to obtain polyhydroxylated flavonoids. Furthermore,


flavonoids constitute a best base chemical structure for new hemisynthetic drugs. Chemical and structural similarities of flavonoids with numerous biomolecules as well as their crucial role in plant-insect and plant-bacterial interactions mak the attractiv clas o phytoconstituents   for biological activity. Their wide spread occurrence, broad spectrum diversity and natural origin make them appropriate chemical scaffolds for novel therapeutic agents. Of many action o flavonoids,   antioxidant  an antiproliferative effects stand out. Given that certain substituents are known to be required or increase their actions, the therapeutic potential  of  selected  flavonoids  is  fairly  obvious.these natural compounds have several great advantages over other therapeutic agents since:

i)    Our diet is rich in these phenolics and they are daily consumed.

ii)   They rarely have any side effects. iii)  They have relatively long half-life.

iv)  They can easily absorbed in intestine after ingestion.

 

The study of flavonoids is complex because of heterogeneity of different molecular structures and the scarcity of data on bioavailability. There is need to improve analytic techniques to allow collection of more data on absorption and excretion. Data on the long term consequences of chronic flavonoid ingestion are especially scare. Finally, we would think that natural, hemisynthetic and synthetic flavonoids alone or in combination with other preventive and/or therapeutic strategies will become an effective future drugs against most common degenerative diseases such as cancer, diabetes, cardiovascular complications.

 

REFERENCES:

 

1.        De Groot H and Raven U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharma Col. 1998; 12:249-255.

2.        Robak J and Gryglewski RJ. Bioactivity of flavonoids. Pol J Pharmacol. 1996; 48:555-564.

3.        Ranaud S and de Lorgeril M. Wine, alcohol, platelets, and the french  paradox  for  coronary  heart  disease.  Lancet.  1992; 339(8808):1523-1526.

4.        Harborne JB. The flavonoids- Advances in Research Since 1980. Chapman and Hall, London. 1988. 1st ed.

5.        Middleton E. The flavonoids. Trends Pharmacol Sci. 1984;5:335-338.

6.         Havsteen B. Flavonoids, a class of natural products of high pharmacological    potency.    Biochem    Pharmacol.    1983;32(7):1141-1148.

7.        Harborne JB. Nature, distribution and function of plant flavonoids.  In  Cody V, Middleton  Elliott  Jr,  Harborne  JB.Plan flavonoid i biology  an medicine biochemical, pharmacological  and structure  activity relationship.  Alan  R Liss, Inc, New York, USA.1986; pp. 15-24.

8.        Barron D and Ibrahim RK. Isoprenylated flavonoids- a survey. Phytochem. 1996; 43(5):921-982.

9.        Harborne  JB  and  Baxter,   H.   The  handbook  of  natural flavonoids. Vol.1-2. John Wiley and son, New York. 1999.

10.     Wong  E.  Chemistry  and  biochemistry  of  plant  pigments. Academic press, London. 1976. 2nd ed.

11.      Das DK. Naturally occurring flavonoids: structure, chemistry and high performance liquid chromatographic methods for separation and characterization. Methods Enzymol. 1994; 234:410-420.

12.     Heller   W   an Forkman G Biosynthesis   in   the flavonoids. In Harborne JB. Advances in research since 1986.Chapmann and Hall Ltd., London.1993; pp. 499-535.

13.     Jensen RA. The shikimate/arogenate pathway: Link between carbohydrate metabolism and secondary metabolism. Physiol Plant. 1986; 66:164.

14.     Dewick PM. The biosynthesis of shikimate metabolites. Nat Prod Rep. 1986; 3:565-588.

15.     Dewick PM. The biosynthesis of shikimate metabolites. Nat Prod Rep. 1988; 5:73-97.

16.     Ayabe   S Udagaw A  an Furuya   T NAD(P)H- dependent    6’-deoxychalcone    synthase    activity    in Glycyrrhiza  echinata  cells  induced  by  yeast  extract. Arch Biochem Biophys. 1988; 261(2):458-462.

17.     Wagner H anFarkas  L. Synthesis of flavonoids. In Harborne JB, Mabry TJ, Mabry H.  The flavonoids Part I. Academic press, New York. 1975; pp. 127-213.

18.     Ayabe S, Udagawa A and Furuya T. Stimulation of chalcone synthase activity by yeast extract in cultured Glycyrrhiza   echinata   cells   an 5-deox flavanone formation by isolated protoplast. Plant Cell Rep. 1988; 7:35-38.

19.     Hakamatsuka T et al. Deoxychalcone synthase from cell suspension  cultures  of Pueraria  lobatia.  ChePharm Bull. 1988; 36(10):4225-4228.

20.     Britsch L. Purification and characterization of flavone synthase I, a 2-oxoglutarate dependent desaturase. Arch Biochem Biophys. 1990; 282(1):152-160.

21.     Koch  an Grisebac H.   Inductio and characterization of NADPH dependent flavone synthase from  cell  cultures  of  soybean.  Naturforch.  1987;  42 c:343-348.

22.     Fischer D et al. Purification and characterization of (+) Dihydroflavonol, 3-hydroxyflavonol 4-reductase from flowers of Dalhia variabilis. Arch Biochem Biophys. 1988; 264(1):40-47.

23.     Britsch  L  and  Grisebach  H.  Purification  and characterization of (2S)-flavanone 3-hydroxylase from Petunia hybrida. Eur J Biochem. 1986; 156:569-577.

24.     Britsch L. Purification of flavanone 3 beta hydroxylase from Petunia hybrida: antibody preparation and characterization of a chemigenetically defined mutant. Arch Biochem Biophys. 1990; 276(2):348-354.

25.     Stic  an Forkman G Biosynthesis   o 3-deoxyanthocyanins with flower extracts from Sinningia cardinalis. Phytochem. 1988; 27:785-789.

26.     Britsch  L,  Ruhnau  and  Forkmann  G.  Molecular cloning  sequence  analysis  and  in  vitro  expression  of flavanone 3 beta-hydroxylase from Petunia hybrida. J Biol Chem. 1992; 267(8):5380-5387.

27.     Beerhues L et al. Flavanone 3-hydroxylase and dihydroflavono oxygenase   activitie in   anthers   of Tulipa. The significance of the Tapetum fraction in the flavonoid  mechanism.  In  thflavonoid  mechanism. Plant Physiol. 1989; 133:743-746.

28.     Stafford   HA  an Lester  HH.   Enzymatic  an non enzymatic reduction of (+)-Dihydroquercetin to its 3, 4 diol. Plant Physiol. 1982; 70:695-698.

29.     Stafford HA. Proanthocyanidins and the lignin connections. Phytochem. 1988; 27:1-6.

30.     Stafford HA and Lester HH. Flavan-3-ol biosynthesis. Plant Physiol 1984; 76:184-186.

31.     Brenda Winkel-Shirley. Flavonoid Biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol. 2001; 126:485-493.

32.     Harborne  JB  and  Christine  AW.  Advances  in  flavonoid research since 1992. Phytochem. 2000; 55:481-504.

33.     Harborne  JB,  Mabry  TJ  and  Mabry  M.  The  flavonoids. Chapmann and Hall, London. 1975. 1st ed.

34.     Allan  J  and  Robinson  R.  An  accessible  derivatives  of chromonol. J Chem Soc. 1924; 125:2192-2195.

35.     Baker     W.     Molecular     rearrangement     of     some     O-acyloxyacetophenone and the mechanism of the production of 3-acylchromones. J Chem Soc. 1933; 55:1381-1389.

36.     Mahal HS and Venkataraman K. Synthetical experiments in the chromone group. Part XIV: The action of sodamide on 1- Acyloxy-2-acetophthanones.  J  Chem  Soc.  1934;  56:1767-1769.

37.     Mulle  e al.   Synthesis   o spin   labele chromones. Synthesis. 2000; 10:1415-1420.

38.     Bois  F  et  al.  A  one  step  synthesis  of  5-hydroxyflavones. Synlett. 1999; 9:1480-1482.

39.     Hauteville  M  et  al.  Synthesis  of  novel  C-methylflavones. Liebigs Ann. 1996; 1217-1222.

40.     Krohn K, Roemer E and Top M. Total synthesis of aklanonic acid and derivatives by Baker-Venkataraman rearrangement. Liebigs Ann. 1996; 271-277.

41.     Geissma TA   an Clinto O.   Flavanone an related compounds I. The preparation of polyhroxychalcones and flavanones. J Amer Chem Soc. 1946; 68(4), 697-700.

42.     Furlong JJP and Nudelman NS. Mechanism of cyclisation of 2’-hydroxychalcone to flavanones. J Chem Soc Perkin Trans II. 1985; 633-639.

43.     Sangwan  NK,  Varma  BS  and  Dhindsa  KS.  Silica  gel  as potentia catalyst   fo isomerizatio o substitute 2’-hydroxychalconeto the corresponding flavanones. Chem Ind. 1984; 6:271-272.

44.     Matsushima R and Kageyama H. Photochemical cyclisation of 2’-hydroxychalcone. J Chem Soc Perkin Trans II. 1985; 743-748.

45.     Maruyama  et al. Conversion of 2’-hyroxychalcones to flavanones catalysed by cobalt Schiff base complex. Tetrahedron Lett. 1989; 30(31):4145-4148.

46.     Kashara  A,  Izumi  T  and  Oshima  M.  new  method  for preparing flavones. Bull Chem Soc Jpn. 1974; 47(10):2526-2528.

47.     Maki  Y  et  al.  Photo-oxidative  cyclisation  of  2’- hydroxychalcones leading to flavones induced by heterocycle n-oxides: high efficiency of pybimido[54-8]pteridine n-oxide for  thphotochemical  dehydrogenation.  Tetrahedron.  1988; 44(11):3187-3194.

48.     Harris KM and Carney RL. Synthesis of 3,5,7-triketo acids and  esters  and  their  cyclisation  to  resorcinol  and phloroglucinol derivatives. Model of biosynthesis of phenolic compounds. J Amer Chem Soc. 1967; 89(25):6734-6741.

49.     Sanicanin Z and Tabakovic I. Electrochemical transformation of  2’-hydroxychalcones  into  flavonoids.  Tetrahedron  Lett. 1986; 27(3):407-408.

50.     Ali SM, Iqubal J and Ilyas M. J Chem Research. 1984; 256.

51.     Emilwic T   an vo Kostaneck S Synthese de 3- oxyflavone. Chem Ber. 1898; 31:696-705.


52.     Algar J and Flynn JP. A new method for the synthesis of flavonols. Proc R Ir Acad sect B. 1934; 42:1-4.

53.     Oyamada  T.  new  method  for  the  synthesis  of flavonol. J Chem Soc Jpn. 1934; 55:1256-1261.

54.     Labeau J, Neviere R and Cotelle N. Beneficial effects of differen flavonoid o functiona recovery   after ischemiand  reperfusion  in  isolated  rat  heart.  Biorg Med Chem Lett. 2001; 11:23-37.

55.     Hercouet A, Le Corre M and Le Floch Y. A simple synthesis of chromones. Synthesis. 1982; 597-599.

56.     Le Floch Y and Le Fleuve M. Syntheses de trihydroxyphenacyclidene triphenylphosphanes. Une nouvelle       voie       daccesaux       dihydroxyflavones. Tetrahedron Lett. 1986; 27:5503-5504.

57.     Subramanian RS and Balasubramanian KK. Mecury (II) trifluoroacetate-mediated transformation of 3-bromo-1- phenylprop-2-ynyl  arly  ethers;  a  novel  synthesis  of flavanones. J Chem Soc Chem Commun. 1990; 1469-1470.

58.     Brack et al. Photochemical formation of 4’-N,N- dimethylamino-3-hydroxyflavone      in      hydrocarbon solutions of 4-N,N-dimethylamino-2’-hydroxychalcone. Tetrahedron Lett. 1999; 40:3995-3998.

59.     Kond T et al. Commelinin, a highly associated metalloanthocyanin present in the blue flower petals of Commelina communis. Nature. 1992; 358:515-517.

60.     Kootstra   A Protectio fro UV-B   induce DNA damage by flavonoids. Plant Mol Biol. 1994; 26(2):771- 774.

61.     Grayer RJ, Harborne JB. A survey of antifungal compound fro highe plants.   Phytochem 1994;37:19-42.

62.     De Groot H. Reactive oxygen species in tissue injury. Hepatogastroenterol. 1994; 41:328-332.63.  

63.     Grace  PA.  Ischaemia-reperfusion  injury.  Br  J  Surg. 1994; 81:637-647.

64.     Wegene T   an Fintelman V.   Flavonoid and bioactivity. Wein Med Wochem Schr. 1999; 149:241-247.

65.     Ares JJ and Outt PE. Gastroprotective agents for the prevention of NSAID induced gastropathy. Curr Pharm Des. 1998; 4:7-36.

66.     Hillwell  B.  Freradicals,  antioxidants  anhuman disease: Curiosity, cause or constipation? Lancet. 1994; 344:721-724.

67.     Fraga CG et al. Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Med Metabol Biol. 1987; 36:717-720.

68.     Ratty AK. Effects of flavonoids on nonenzymatic lipid peroxidation:  structure  activity  relationship.  Biochem Med Metabol Biol. 1988; 39;67-79.

69.     Bors W et al. Flavonoids as antioxidant: Determination of  radical  scavenging  efficiencies.  Methods  Ezymol. 1990; 186:343-355.

70.     Cotelle    e al.   Antioxidan activity   o hydroxy flavonoids. Free Radic Biol Med. 1996; 20:35-43.

71.     Rice-Evans CA, Nicholas JM and Paganga G. Structure- antioxidant  activity  relationships  of  flavonoids  and phenolic acid. Free Radic Biol Med. 1996; 20(7)-933-956.

72.     Amic D et al. Structure radical scavenging activity relationships  of  flavonoids.  Croat  Chem  Act.  2003; 76:55-61.

73.     Farkas O, Jakus J and Heberger K. Quantitative structure- antioxidant activity relationship of flavonoid compounds. Molecules. 2004; 9:1079-1088.

74.     Havsteen B. Flavonoids, a class of natural products of high pharmacological    potency.    Biochem    Pharmacol.    1983;32(7):1141-1148.

75.     Tencate JW et al. Biological activity of a semisynthetic flavonoid  O-(β-hydroxyethyl) rutosine: Light scattering and metabolic studies of human red cells and platelets. Clin Chem. 1973; 19:31-35.

76.     Selway JWT. Antiviral activity of flavones and flavans. In CodV,  Middleton  E,  Harborne  JB.  Plant  flavonoids  in biology  and  medicine:  Biochemical,  pharmacological  and structure activity relationships. Alan R Liss, Inc, New York. 1986. pp. 521-536.

77.     Thomas PRS, Nash GB and Dormandly JA. White cells accumulation  in  dependent  legs  of  patients  with  venous hypertension: A possible mechanism for trophic changes in the skin. Br Med J. 1988; 296:1673-1695.

78.     Loewenstein WR. Junctional Intercellular communication and the control of growth. Biochem Biophys Acta. 1979; 560:1-65.

79.     Ng TB et al. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV transcriptase inhibitors. Life Sci. 1997; 61:933-949.

80.     Gerdin B and Srensso E. Inhibitory effect of flavonoids on increased  microvascular  permeability  induced  by  various agents in rat skin. Int J Micro Cir Clin Exp. 1983; 2:39-46.

81.     Alarcon DL et al. Antiulcerogenic activity of flavonoids and gastric protection. Ethnopharmacol. 1994; 42:161-170.

82.     Izzo AA et al. Effect of quercetin on gastrointestinal tract. Phyto Ther Res. 1994; 8:179-185.

83.     Carlo GD et al. Inhibition of intestinal motility and secretion by flavonoids in mice and rats; structure activity relationships. J Pharm Pharmcol. 1993; 45:1045-1059.

84.     Lorenz W et al. Action of several flavonoids on enzyme of histidine metabolism in vivo. In Cz Maslinski. Histamine. Hutchinson and Ross, Pennsylvania. 1994. pp. 265-269.

85.     Lee SJ et al. Anti-inflammatory activity of naturally occurring flavone  and  flavonol  glycosides.  Arch  Pharm  Res.  1993; 16(1):25-28.

86.     Hang T et al. Evaluation of anti-inflammatory effects of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med. 2002; 68(2):268-271.

87.     Shahid  F, Yang  Z  anSaleemi  ZO.  Natural  flavonoids  as stabilizers. J Food Lipids. 1998; 1:69-75.

88.     Farmica  JV  and  Regelson  W.  Review  of  the  biology  of quercetin and related bioflavonoids. Fd Chem Toxic. 1995;33(12):1061-1080.

89.     Ferrandiz ML and Alcaraz MJ. Anti-inflammatory activity and inhibition  of  arachidonic  acid  metabolism  by  flavonoids. Agent and Actions. 1991; 32(3/4):283-288.

90.     Kim HP et al. Effects of naturally occurring flavonoids and bioflavonoids on epidermal cycloxygenase and lipoxygenase from guinea pigs. Prostag Leukot Essent Fatty acids. 1998; 58:17-24.

91.     Jachak  SM.  Natural  products:  Potential  source  of  COX inhibitors. CRIPS. 2001; 2(1):12-15.

92.     Vessal M, Hemmati M and Vasei M. Antidiabetic effects of quercetin   i streptozocin   induce diabetic   rats.   Comp Biochem Physiol C. 2003; 135:357-364.

93.     Hif CS and Howell SL. Effects of epicatechin on rat islets of langerhans. Diabetes. 1984; 33:291-296.

94.     Hif  CS  and  Howell  SL.  Effects  oflavonoidon  insulin secretioan45Ca+2  handling in  rat islets of langerhans. J Endocrinol. 1985; 107:1-8.


95.     Iijima K and Aviram M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol. 2001; 12:41-48.

96.     Bernatova  I  et  al.  Wine  polyphenols  improve cardiovascular remodeling and vascular function in NO- deficient hypertension. Am J Physiol Heart Cir Physiol. 2002; 282:942-948.

97.     Jayakody TL et al. Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. Can J Physiol Pharmacol. 1985; 63:1206-1209.

98.     Hertag MG et al. Dietary antioxidant flavonoids and risk of  coronary  heart  disease:  the  zutphen  elderly  study. Lancet. 1993; 342:1007-1011.

99.     Hertog MG et al. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer. 1993; 20:21-29.

100.   Andriambeloson  E  et al. Nitric oxide productioand endothelium dependent vasorelaxation induced by wine polyphenols   in   ra aorta Br    Pharmacol.   1997; 120:1053-1058.

101.   Burns J et al. Relationship among antioxidant activity, vasidilation capacity and phenolic content of red wines. J Agric Food Chem. 2000; 48:220-230.

102.   De-whallely C  et  al. Flavonoids inhibit the oxidative modification of low density lipoprotein by macrophages. Biochem Pharmacol. 1990; 39:1743-1750.

103.   Fuhrman B, Lavy A and Aviram M. Consumption of red wine  with  meals  reduces  thsusceptibility of human plasma     and     low-density     lipoproteins     to     lipid peroxidation. Am Soc Nutr. 1995; 61:549-554.

104.   Arai Y et al. Dietary intake of flavonols, flavones and isoflavone b Japanese wome an th inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr. 2000; 130:2243-2250.

105.   Lou FQ et al. A study on tea pigment in prevention of antherosclerosis.  Chin  Med  J  (Engl).  1989;  102:579- 583.

106.   Osman HE et al. Grape juice but not orange or grapefruit juice  inhibits  plate  activity  in  dogs  and  monkey’s.  J Nutr. 1998; 128:2307-2312.

107.   Gryglewsk RJ   e al.   On   the  mechanism  of  anti thrombotic  action  of flavonoids.  Biochem Pharmacol. 1987; 36:317-322.

108.   Alcaraz MJ and Ferrandiz ML. Modification of arachidonic metabolism by flavonoids. J Ethnopharmacol. 1987; 21:209- 229.

109.   Kandaswami C and Middleton E. Free radical scavenging and antioxidant activity of plant flavonoids. In Armstrong D. Free radicals  in  diagnostic  medicine.  PlenuPress,  New  York. 1994; 2nd ed: pp. 351-376.

110.   Lackeman  GM  et  al.  Chronotropic  effect  of  quercetin  on guinea pig right atrium. J Planta Med. 1986; 52:433-439.

111.   Huesken  BCP  et  al.  Flavonoids as  cardioprotectivagents. Cancer Chemotheapy Pharmacol. 1995; 37:55-62.

112.   Bast    e al.   Protectors   against   doxorubicin-induced cardiotoxicity: Flavonoids. Cell Biol Toxicol. 2007; 23:39-47.

113.   Kontruck SJ et al. Antiulcer and gastroprotective effects of solon, a synthetic flavonoid derivative of sophorandin. Role of endogenous prostaglandins. Bur J Pharmac. 1986; 125:185-192.

114.   Izzo  AA  et  al.  Antiulcer  effects  of  flavonoids.  Role  of endogenous PAF. Phytotherapy Res. 1991; 8:179-81.

115.   Murakami  S,  Muramatsu  M  and  Otomo  S.  Gastric  H+/K+ ATPase inhibition by catechins. J Pharm Pharmacol. 1992; 44:926-928.

116.   Kim HK, Namgoong SY and Kim HP. Biological actions of flavonoids-I. Arch Pharmacol Res. 1993; 16:18-27.

117.   Gill B, et al. The flavonoids. Life Sci. 1994; 54:333-339.

118.   Hirano T, Gotoh M and Oak K. Natural flavonoids and lignans are plant cytostatic agents against Human Leukemic HL-60 cells. Life Sci. 1994; 55:1061-1069.

119.   Wei H et al. Inhibitory effect of Apigenin, a plant flavonoids on epidermal ornithine decarboxylase skin tumor promotion in mice. Cancer Res. 1990; 50: 499-502.

120.   Griebel    e al.   Pharmacologica studie o synthetic flavonoids:   Compariso with  diazepam.   Neuropharmacol.1999; 38:965-977.

121.   Starvic  B.  Mutagenic  food  flavonoids.  Fed  Proc.  1984;43:2344.

122.   Dunnick  JK  and  Hailey  JR.  Toxicity  and  carcinogenicity studies of quercetin, a natural component of food. Fundam Appl Toxicol. 1992; 19:423-431.

123.   Plakas SM, Lee TC and Wolke RE. Absence of overt toxicity from feeding the flavonol, quercetin t rainbow trout (Calmo gairdneri). Food Chem Toxicol. 1985; 23:1077-1080.

 

Received on 26.05.2008    Modified on 10.07.2008

Accepted on 28.08.200 © RJPT All right reserved

Research J. Pharm. and Tech. 1(3): July-Sept. 2008; Page 132-143